Rongqing Li

1.1k citations
48 papers · 763 indexed · h-index 15
Topics
RNA modifications and cancer (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)Epigenetics and DNA Methylation (5 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Rongqing Li

40 papers receiving 755 citations

Peers

Rongqing Li
Comparison fields: 5 of 102
  • Molecular Biology 384
  • Cancer Research 189
  • Pulmonary and Respiratory Medicine 157
  • Immunology 124
  • Epidemiology 108
Replace Kuang-Tai Kuo with:
Kuang-Tai Kuo Taiwan
Xibing Zhuang China
Shang Cai China
Yuhua Huang China
Ke Huang China
Qinghua Dong China
Binghui Li China
Sehwan Shim South Korea
Qichen Ding China
Rongqing Li relative to Kuang-Tai Kuo Taiwan Kuang-Tai Kuo's profile →
Citations per field
00.5×2.5×
Kuang-Tai Kuo · 1×
Citations per year

Countries citing papers authored by Rongqing Li

Since Specialization
Citations

This map shows the geographic impact of Rongqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongqing Li more than expected).

Fields of papers citing papers by Rongqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongqing Li. The network helps show where Rongqing Li may publish in the future.

Co-authorship network of co-authors of Rongqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rongqing Li. A scholar is included among the top collaborators of Rongqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongqing Li. Rongqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 6
4 1
5 5
6 2
7 0
8 9
9 99
10 2
11 4
12 4
13 12
14 67
15 8
16 19
17 1
18 22
19 24
20
Effect of various laparoscopic coeliac enviroment on pH value of arterial blood and abdominal cavity in a rat model
1

About Rongqing Li

Rongqing Li is a scholar working on Cancer Research, Immunology and Otorhinolaryngology, having authored 48 papers that have together received 763 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (189 citations), Immunology (124 citations) and Molecular Biology (384 citations). Rongqing Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Dangheng Wei, Wang Zuo, Xiao‐Qing Tang, Caihong Lv, Chengbin Wang, Daming Cui, Junshuang Zhao, Juan Peng, Yang Jiang and Yingliang Liu. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026